BLV
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
A Pilot Study on Curator-Guided Multilingual Art Description for Blind and Low-Vision Audiences with Small Vision-Language Models
arXiv:2605.31080v1 Announce Type: new Abstract: Blind and low-vision (BLV) audiences remain underserved by visual art descriptions, particularly across languages and in museum settings where privacy and intellectual-property constraints may favour small on-premise vision-language models (VLMs). This pilot study investigates curator-guided multilingual art description with Qwen2.5-VL-3B-Instruct for German, Romanian, and Serbian. We construct a parallel BLV-oriented caption corpus from...
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutions
Announce Type: replace Abstract: The entry inhibitor Bulevirtide (BLV) was recently approved in Europe for treatment of chronic hepatitis D virus (HDV) infection, which is considered the most severe viral hepatitis infection. Theory indicates that models that account for free virus and infected cells, but do not include target cell dynamics (historically called the two-equation model) are limited to predicting a monophasic viral decline for antiviral agents that act only to block viral...
A Visually Impaired Assistance Benchmark for VLM-as-a-Judge Evaluation
arXiv:2605.31351v1 Announce Type: new Abstract: AI-based Visually Impaired Assistance (VIA) remains challenging, largely due to the high cost of human evaluation. The VLM-as-a-Judge paradigm may offer a promising alternative, although it has mostly been studied in general domains. We therefore ask whether such judges can be trusted for VIA tasks.